Trial Profile

Phase 2b study of IFNα-Kinoid

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 15 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha kinoid (Primary)
Indications Systemic lupus erythematosus
Focus Therapeutic Use

Most Recent Events

15 May 2023 New trial record
18 Mar 2023 According to a Neovacs media release, Neovacs and Biosense Global LLC have signed a new partnership agreement to Kinoid product in the treatment of lupus and this agreement allows resumption of clinical trials in China, fully supported by Biosense Global. Biosense Global will now bear the entire costs of these new clinical trials for the mutual benefit of both partners

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com